210 related articles for article (PubMed ID: 21478220)
21. Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication.
Wolf M; Korja M; Karhu R; Edgren H; Kilpinen S; Ojala K; Mousses S; Kallioniemi A; Haapasalo H
BMC Cancer; 2010 May; 10():181. PubMed ID: 20444257
[TBL] [Abstract][Full Text] [Related]
22. Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.
Bain GH; Collie-Duguid E; Murray GI; Gilbert FJ; Denison A; McKiddie F; Ahearn T; Fleming I; Leeds J; Phull P; Park K; Nanthakumaran S; Matula KM; Grabsch HI; Tan P; Welch A; Schweiger L; Dahle-Smith A; Urquhart G; Finegan M; Petty RD
Br J Cancer; 2014 Mar; 110(6):1525-34. PubMed ID: 24569475
[TBL] [Abstract][Full Text] [Related]
23. Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.
McKay SC; Unger K; Pericleous S; Stamp G; Thomas G; Hutchins RR; Spalding DR
HPB (Oxford); 2011 May; 13(5):309-19. PubMed ID: 21492330
[TBL] [Abstract][Full Text] [Related]
24. Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation.
Langer R; Rauser S; Feith M; Nährig JM; Feuchtinger A; Friess H; Höfler H; Walch A
Mod Pathol; 2011 Jul; 24(7):908-16. PubMed ID: 21516080
[TBL] [Abstract][Full Text] [Related]
25. BAC clones related to prognosis in patients with esophageal squamous carcinoma: an array comparative genomic hybridization study.
Hirasaki S; Noguchi T; Mimori K; Onuki J; Morita K; Inoue H; Sugihara K; Mori M; Hirano T
Oncologist; 2007 Apr; 12(4):406-17. PubMed ID: 17470683
[TBL] [Abstract][Full Text] [Related]
26. EGFR status and KRAS/BRAF mutations in intestinal-type sinonasal adenocarcinomas.
García-Inclán C; López F; Pérez-Escuredo J; Cuesta-Albalad MP; Vivanco B; Centeno I; Balbín M; Suárez C; Llorente JL; Hermsen MA
Cell Oncol (Dordr); 2012 Dec; 35(6):443-50. PubMed ID: 23055340
[TBL] [Abstract][Full Text] [Related]
27. ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass.
Jansen R; Moehlendick B; Bartenhagen C; Tóth C; Lehwald N; Stoecklein NH; Knoefel WT; Lachenmayer A
Sci Rep; 2018 Jul; 8(1):10637. PubMed ID: 30006612
[TBL] [Abstract][Full Text] [Related]
28. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.
Shibata T; Uryu S; Kokubu A; Hosoda F; Ohki M; Sakiyama T; Matsuno Y; Tsuchiya R; Kanai Y; Kondo T; Imoto I; Inazawa J; Hirohashi S
Clin Cancer Res; 2005 Sep; 11(17):6177-85. PubMed ID: 16144918
[TBL] [Abstract][Full Text] [Related]
29. High-resolution detection of recurrent aberrations in lung adenocarcinomas by array comparative genomic hybridization and expression analysis of selective genes by quantitative PCR.
Zhu H; Wong MP; Tin V
Int J Oncol; 2014 Jun; 44(6):2068-76. PubMed ID: 24728343
[TBL] [Abstract][Full Text] [Related]
30. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.
Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P
J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645
[TBL] [Abstract][Full Text] [Related]
31. Genomic aberrations in lung adenocarcinoma in never smokers.
Job B; Bernheim A; Beau-Faller M; Camilleri-Broët S; Girard P; Hofman P; Mazières J; Toujani S; Lacroix L; Laffaire J; Dessen P; Fouret P;
PLoS One; 2010 Dec; 5(12):e15145. PubMed ID: 21151896
[TBL] [Abstract][Full Text] [Related]
32. High resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell lymphoma that predict response to immuno-chemotherapy.
Kreisel F; Kulkarni S; Kerns RT; Hassan A; Deshmukh H; Nagarajan R; Frater JL; Cashen A
Cancer Genet; 2011 Mar; 204(3):129-37. PubMed ID: 21504712
[TBL] [Abstract][Full Text] [Related]
33. High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma.
Sepulveda JL; Komissarova EV; Kongkarnka S; Friedman RA; Davison JM; Levy B; Bryk D; Jobanputra V; Del Portillo A; Falk GW; Sonett JR; Lightdale CJ; Abrams JA; Wang TC; Sepulveda AR
Int J Cancer; 2019 Nov; 145(10):2754-2766. PubMed ID: 31001805
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
Akagi T; Ito T; Kato M; Jin Z; Cheng Y; Kan T; Yamamoto G; Olaru A; Kawamata N; Boult J; Soukiasian HJ; Miller CW; Ogawa S; Meltzer SJ; Koeffler HP
Int J Cancer; 2009 Nov; 125(10):2349-59. PubMed ID: 19670330
[TBL] [Abstract][Full Text] [Related]
35. An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.
Chitale D; Gong Y; Taylor BS; Broderick S; Brennan C; Somwar R; Golas B; Wang L; Motoi N; Szoke J; Reinersman JM; Major J; Sander C; Seshan VE; Zakowski MF; Rusch V; Pao W; Gerald W; Ladanyi M
Oncogene; 2009 Aug; 28(31):2773-83. PubMed ID: 19525976
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
37. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
[TBL] [Abstract][Full Text] [Related]
38. Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York.
Varma G; Varma R; Huang H; Pryshchepava A; Groth J; Fleming D; Nowak NJ; McQuaid D; Conroy J; Mahoney M; Moysich K; Falkner KL; Geradts J
Br J Cancer; 2005 Sep; 93(6):699-708. PubMed ID: 16222315
[TBL] [Abstract][Full Text] [Related]
39. Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.
Hjortland GO; Meza-Zepeda LA; Beiske K; Ree AH; Tveito S; Hoifodt H; Bohler PJ; Hole KH; Myklebost O; Fodstad O; Smeland S; Hovig E
BMC Cancer; 2011 Oct; 11():455. PubMed ID: 22014070
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.
Seo AN; Yang JM; Kim H; Jheon S; Kim K; Lee CT; Jin Y; Yun S; Chung JH; Paik JH
Br J Cancer; 2014 May; 110(11):2688-99. PubMed ID: 24809777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
